Skip to content
ChickenStockChickenStock
ResearchDRTS
Alpha Tau Medical logo

Alpha Tau Medical (DRTS) stock

NASDAQ

$13.37+0.07%(+0.01)

As of the Nov 13, 2026 close (U.S. Eastern)

Events and reference metrics · 1

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 13, 2026 · Financial period · Latest fiscal year

Latest fiscal-year financials · Computed in-house by ChickenStock

P/E

-27.37x

Net loss — not comparable

P/B

15.29x

P/S

—

Latest earnings

Recent results in a standard quarterly format were not found in SEC filings.

Some foreign companies file only annual or current reports, so quarterly figures may be missing.

See recent SEC filings →

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

4 SEC filings
  • Levy RaphiChief Financial Officer · Aug 21, 2026Open-market sale2,871 shares · $43K
    Avg. price $15.002890,180 shares held after
  • Levy RaphiChief Financial Officer · Aug 21, 2026Option exercise2,871 shares · $9K
    Avg. price $2.9893,051 shares held after
  • Levy RaphiChief Financial Officer · Aug 11, 2026Open-market sale17,730 shares · $248K
    Avg. price $14.003290,180 shares held after
  • Levy RaphiChief Financial Officer · Aug 11, 2026Option exercise17,730 shares · $53K
    Avg. price $2.98107,910 shares held after

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Alpha Tau Medical (DRTS) stock information

NASDAQ

Alpha Tau Medical (DRTS) is listed on NASDAQ. Its market capitalization is about $1.2B. On trailing-twelve-month earnings the P/E ratio is -27.37, and the P/B ratio is 15.29. Return on equity is -55.8%. These figures are computed in-house from official filings and are reference information only.

Alpha Tau Medical — frequently asked questions

What is the P/E ratio of Alpha Tau Medical (DRTS)?
On a trailing-twelve-month basis, DRTS trades at a P/E ratio of -27.37. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Alpha Tau Medical?
DRTS has a market capitalization of about $1.2B. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.